查詢結果分析
相關文獻
頁籤選單縮合
題 名 | Neuroleptic Malignant Syndrome after the Use of Venlafaxine in a Patient with Generalized Anxiety Disorder |
---|---|
作 者 | Lu, Tsung-chien; Chu, Pei-lun; Wu, Chi-shin; Tsai, Kuang-chau; Chen, Wen-jone; | 書刊名 | Journal of the Formosan Medical Association |
卷 期 | 105:1 民95.01 |
頁 次 | 頁90-93 |
分類號 | 418.21 |
關鍵詞 | Neuroleptic malignant syndrome; Venlafaxine; |
語 文 | 英文(English) |
英文摘要 | Neuroleptic malignant syndrome (NMS) is a potentially lethal adverse reaction to neuroleptics, which is characterized by hyperthermia, extrapyramidal symptoms, altered consciousness and autonomic dysfunction. Although NMS is most commonly induced by the high-potency neuroleptics, its development has also been associated with the use of non-neuroleptic agents that block central dopamine pathways. A 68-year-old man with generalized anxiety disorder and depressive symptoms presented at the emergency department (ED) with high fever, tremor, muscle rigidity, rhabdomyolysis and altered mental status. NMS was considered to have been caused by the recent addition and subsequent dose increase in his treatment regimen of venlafaxine, a serotonin norepinephrine reuptake inhibitor. He was successfully treated with bromocriptine, lorazepam, and fluid hydration in the ED and intensive care unit. |
本系統中英文摘要資訊取自各篇刊載內容。